Updated clinical and preliminary correlative results of ARIEL2, a Phase 2 study to identify ovarian cancer patients likely to respond to rucaparib

Category Primary study
JournalEuropean Journal of Cancer
Year 2014
This article has no abstract
Epistemonikos ID: f56e3d964ec3a57b45c8a10f3c316ecc70fcc6df
First added on: Feb 06, 2025